Gastrointestinal Surgery

More About Gastrointestinal Surgery

Spectrum Health is nationally ranked as one of the top 50 Gastroenterology and Gastrointestinal Surgery program by U.S. News and World Report.  Our team board certified fellowship-trained bariatric, colorectal and foregut surgeons, and surgical oncologists specializes in advanced treatment of disorders of the digestive tract, liver and pancreas.

Program highlights:

  • Michigan’s largest hospital-based bariatric surgery program 
  • West Michigan’s largest and most experienced colorectal surgery team 
  • One of only three centers in Michigan implanting the LINX® magnetic sphincter augmentation for gastroesophageal reflux disease (GERD) 
  • West Michigan’s only comprehensive program for diagnosing and treating tumors of the gastrointestinal tract and foregut 
  • Largest and most comprehensive program in the region focused on the diagnosis and treatment of upper gastrointestinal malignancies

Our experienced board-certified colorectal surgeons treat conditions including colorectal cancer, inflammatory bowel disease, diverticular disease, polyposis syndromes, anorectal problems, and pelvic floor disorders such as rectal prolapse. 

The Colorectal Cancer Multispecialty Clinic provides you the opportunity for to meet with a team of experts in a single visit. Each patient is reviewed in our colorectal multispecialty conference, or tumor board, to develop a personalized and comprehensive treatment plan.

The Upper Gastrointestinal (UGI) Tumor Board (multispecialty team conference) is held weekly at Spectrum Health Cancer Center to prospectively review complex patient cases. Together, the board determines the best treatment option for each patient. Among the specialties represented on this tumor board are surgical, medical and radiation oncology; pathology; gastroenterology; interventional radiology; research; and genetics. 

We are the only provider in West Michigan offering subspecialty tumors boards, multidisciplinary care and advanced technologies for difficult-to-treat upper gastrointestinal cancers, dramatically expanding treatment options for patients.